drugset / Trial / NCT03480906
Eyenovia MiDD Usability Study
Non-randomizedCrossoverSingle-blindOther
Summary
This study is to evaluate the usability and patient tolerability for microtherapeutic dosing of commercially available ocular medication via the Eyenovia microdose delivery system (MiDD)
Timeline
- Start
- 2018-03-12
- Primary completion
- 2018-03-17
- Completion
- 2018-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | — | Topical |
Indications
No indication recorded.